Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eltrombopag and Azacitidine in MDS and AML
NCT01488565Phase 2Completed
- Sponsor
- Peter MacCallum Cancer Centre
- Start
- Dec 2010
- Primary completion
- May 2014
- Countries
- 1
01
Overview
Phase 2, open-label trial of eltrombopag in Thrombocytopenia, sponsored by Peter MacCallum Cancer Centre. Started Dec 2010; status: completed.
02
Drugs
eltrombopag
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on NCT01488565.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01488565.